文献速递母胎医学产科

先天性孤立性胼胝体完全缺如连续病例系列的长期结局

Long-term outcome of consecutive case series of congenital isolated agenesis of corpus callosum.
PubMed 文献 · Ultrasound Obstet Gynecol · 2022-01-01

单中心回顾性病例系列纳入2004年1月至2020年7月产前诊断疑似胼胝体异常的128例妊娠,其中53例产前诊断为孤立性胼胝体完全缺如,最终26例患儿纳入分析,中位随访3年。3例(11.5%)有严重神经发育障碍,7例(26.9%)有轻度障碍,16例(61.5%)神经发育正常;作者建议对所有先天性孤立性胼胝体完全缺如病例进行长期随访。

要点

  • 26例孤立性胼胝体完全缺如患儿中,16例(61.5%)神经发育正常,7例(26.9%)轻度障碍,3例(11.5%)严重障碍。
  • 3例严重障碍患儿全量表智商分别为50、64和63,其余患儿中位101(范围89-119)。
  • 作者建议对所有先天性孤立性胼胝体完全缺如病例进行长期随访,以尽早识别细微神经发育障碍。

核心结论

  • 本研究中88%的孤立性胼胝体完全缺如患儿神经发育未严重受损。
  • 作者建议对所有先天性孤立性胼胝体完全缺如病例进行长期随访,以尽早识别细微神经发育障碍。

研究设计与样本

  • 单中心回顾性病例系列,复习2004年1月至2020年7月转诊至胎儿治疗单元的疑似胼胝体异常胎儿病历。
  • 共识别128例胎儿胼胝体异常妊娠(诊断时平均孕周24.5周,范围21-34周),其中53例产前诊断为孤立性胼胝体完全缺如。
  • 53例中12例终止妊娠,1例孕24周宫内死亡,13例失访;剩余27例中1例因出生后诊断的8p21.3q11.21嵌合重复染色体异常被排除,最终26例纳入分析。
  • 存活患儿纳入本机构神经发育随访项目,包括出生后磁共振成像、系列神经系统检查和按年龄标准化测试的神经发育评估;偏远地区家庭接受结构化临时电话访谈。

主要发现

  • 26例纳入分析患儿的中位神经发育随访时间为3年(范围1-16年)。
  • 3例(11.5%)有严重神经发育障碍,其中2例出生后诊断为遗传综合征(Mowat-Wilson综合征和Vici综合征),产前无法诊断。
  • 7例(26.9%)有轻度神经发育障碍,16例(61.5%)神经发育结局正常。
  • 3例严重神经发育障碍患儿全量表智商分别为50、64和63;其余患儿全量表智商在正常范围(中位101,范围89-119)。

临床怎么用

  • 作者建议对所有先天性孤立性胼胝体完全缺如病例进行长期随访,以尽早识别细微神经发育障碍。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the long-term outcome of children with prenatally diagnosed isolated complete agenesis of the corpus callosum (cACC). METHODS: In this single-center case series, we reviewed retrospectively the charts of fetuses referred to our fetal therapy unit from January 2004 to July 2020 for a suspected anomaly of the corpus callosum (CC). Cases with prenatally diagnosed isolated cACC were included. Fetal karyotype and comparative genomic hybridization microarray of amniotic fluid, in addition to fetal magnetic resonance imaging, were offered to all pregnant women with a diagnosis of fetal CC malformation. The surviving children were enrolled in the neurodevelopmental follow-up program at our institution, which included postnatal magnetic resonance imaging, serial neurological examinations and neurodevelopmental evaluations with standardized tests according to age. Families living in remote areas or far from our institution were offered a structured ad-hoc phone interview. RESULTS: A total of 128 pregnancies with fetal CC malformation were identified (mean gestational age at diagnosis, 24.5 (range, 21-34) weeks), of which 53 cases were diagnosed prenatally with apparently isolated cACC. Of these, 12 cases underwent termination of pregnancy, one resulted in intrauterine demise at 24 weeks of gestation and 13 cases were lost to follow-up. Of the remaining 27 children, one was excluded due to an associated chromosomal anomaly (8p21.3q11.21 mosaic duplication) diagnosed after birth, which could have been detected prenatally if the parents had consented to amniocentesis. In the 26 children included in the analysis, neurodevelopmental follow-up was available for a median of 3 (range, 1-16) years. Three (11.5%) infants had severe neurodevelopmental impairment, two of which were diagnosed postnatally with a genetic syndrome (Mowat-Wilson syndrome and Vici syndrome) that would not have been diagnosed prenatally. Seven (26.9%) children had mild neurodevelopmental impairment and 16 (61.5%) had normal neurodevelopmental outcome. The Full-Scale Intelligence Quotients of the three children with severe neurodevelopmental impairment were 50, 64 and 63, respectively, while that of the remaining children was in the normal range (median, 101; range, 89-119). CONCLUSIONS: In 88% of the children with cACC included in this study, neurodevelopment was not severely impaired. However, long-term follow-up is recommended in all cases of congenital isolated cACC to recognize subtle neurodevelopmental disorders as early as possible. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Lanna M, Scelsa B, Cutillo G, et al. Long-term outcome of consecutive case series of congenital isolated agenesis of corpus callosum. Ultrasound Obstet Gynecol. 2022. PMID: 35274783. doi:10.1002/uog.24898

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。